Stay updated on GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Sign up to get notified when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.

Latest updates to the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page
- Check4 days agoChange DetectedA consolidated Locations section has been added listing study sites across the US, Canada, and Europe, replacing the previous individual location blocks. The page also shows an updated Revision: v3.3.3.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page shows a new site revision (Revision: v3.3.2) and a prior revision (Revision: v3.3.1) in the footer. No study data, eligibility, or outcome content appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1, which does not change the clinical trial details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedA general government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedNo significant changes to core study information were observed; the updates appear to be minor UI/layout adjustments that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedCore content updated to reflect operating-status notice and v3.2.0 release; prior v3.0.2 reference removed.SummaryDifference4%

Stay in the know with updates to GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-2 Study RVT-1401 in Graves' Ophthalmopathy Clinical Trial page.